Dr. Reed Loring Levine, MD

Dr. Levine practices at Synovation Medical Group in Pasadena, California.

Dr. Levine's NPI, 1386844868, was assigned on July 23, 2007. Dr. Levine graduated from New York University School of Medicine in 2004. Dr. Levine's California license number on file is A94916.

Dr. Levine's primary practice is Synovation Medical Group, at 1017 S Fair Oaks Ave, Pasadena, CA 91105-2621. The practice phone is (626) 403-6200.

Dr. Levine's primary practice is Synovation Medical Group in Pasadena, California. The medical group on file is Synovation Medical Group. Dmand AI also links Dr. Levine to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levine practices, 2 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Levine's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Levine is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Levine's licenses on file in 2 states: California and Texas.

Dmand AI lists back pain injection, drug use disorders, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Levine treats.

CMS data shows 1,060 Medicare services from Dr. Levine across 9 procedure codes in 2024, for 238 Medicare patients. Medicare paid $78,229 for them.

CMS counts 238 Medicare patients who saw Dr. Levine in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have arthritis, and 74% have high cholesterol. 54% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levine's median patient age at 65, with 59% women.

In 2024, Dr. Levine wrote 1,843 Medicare Part D claims for 223 patients. 85% of them were for generic drugs. CMS names the drug for 1,738 of them, across 35 drugs with 11 or more claims each, at $219,856 in total drug cost. In 2023, CMS named 2,345 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Levine for performance year 2024, reported individually. Dr. Levine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levine as offering telehealth.

Dmand AI links 3 papers to Dr. Levine in 2020. Dr. Levine's most frequent co-author is Mauro Walsh Zappaterra, MD, PhD.

CMS Open Payments shows 1,741 general payments to Dr. Levine from 65 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Depomed, Inc. paid the most, $185,469.

Dmand AI lists 1 award for Dr. Levine, most recently CMS Stage 1 EHR in 2013.

Dr. Levine graduated from New York University School of Medicine in 2004. Dr. Levine is a member of AAN.

Dr. Levine is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.